Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.

被引：1
|
作者：
Brieau, Bertrand
Dahan, Laetitia
De Rycke, Yann
Boussaha, Tarek
Vasseur, Philippe
Tougeron, David
Lecomte, Thierry
Coriat, Romain
Bachet, Jean Baptiste
Claudez, Pierre
Zaanan, Aziz
Soibinet, Pauline
Desrame, Jerome
Thirot-Bidault, Anne
Trouilloud, Isabelle
Mary, Florence
Locher, Christophe
Marthey, Lysiane
Cacheux, Wulfran
Lievre, Astrid
机构：
[1] Hop Cochin, F-75674 Paris, France
[2] Marseille Univ Hosp, Marseille, France
[3] Inst Curie, Dept Biostat, Paris, France
[4] Hop St Antoine, AP HP, F-75571 Paris, France
[5] CHU Poitiers, Poitiers, France
[6] Univ Poitiers Hosp, Dept Gastroenterol, Poitiers, France
[7] Ctr Hosp Trousseau, Tours, France
[8] Paris Descartes Univ, Cochin Teaching Hosp, AP HP, Paris, France
[9] Ctr Hosp Univ Pitie Salpetriere, Paris, France
[10] CHU St Etienne, St Etienne, France
[11] HEGP, Dept Gastroenterol, Paris, France
[12] CHU Reims, Reims, France
[13] Hop Prive Jean Mermoz, Lyon, France
[14] Hop Bicetre, Dept Hepatogastroenterol, Le Kremlin Bicetre, France
[15] Ambroise Pare, Paris, France
[16] Hop Avicenne, F-93009 Bobigny, France
[17] Meaux Hosp, Dept Hepatogastroenterol, Meaux, France
[18] Hop Bicetre, Le Kremlin Bicetre, France
[19] Inst Curie, Paris, France
[20] Inst Curie, Dept Med Oncol, St Cloud, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.4093
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4093
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Second-line FOLFOX chemotherapy for advanced biliary tract cancer
    Wei, Fangqiang
    LANCET ONCOLOGY, 2021, 22 (07): : E284 - E284
  • [22] Second-line treatment options in advanced thymic carcinoma after failure of platinum-based chemotherapy: A multicenter retrospective study
    Wang, Yang
    Zhang, Xuanye
    Tian, Dan
    Han, Sen
    Zhang, Jie
    Nie, Jun
    Dai, Ling
    Hu, Weiheng
    Chen, Xiaoling
    Ma, Xiangjuan
    Tian, Guangming
    Wu, Di
    Zhang, Ziran
    Long, Jieran
    Fang, Jian
    CANCER MEDICINE, 2023, 12 (03): : 2303 - 2311
  • [23] FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy
    Roussot, Nicolas
    Vincent, Julie
    Palmier, Remi
    Constantin, Guillaume
    Bengrine, Leila
    Fumet, Jean-David
    Ghiringhelli, Francois
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [24] The role of second-line chemotherapy after gemcitabine failure in patients with advanced pancreatic cancer
    Boeck, Stefan
    Heinemann, Volker
    FUTURE ONCOLOGY, 2008, 4 (01) : 41 - 50
  • [25] Second-Line Chemotherapy in Elderly Patients with Advanced Biliary Tract Cancer: A Multicenter Real-World Study
    Rizzo, Alessandro
    Salati, Massimiliano
    Frega, Giorgio
    Merz, Valeria
    Caputo, Francesco
    Di Federico, Alessandro
    Palloni, Andrea
    Carloni, Riccardo
    Ricci, Angela Dalia
    Gadaleta-Caldarola, Gennaro
    Messina, Carlo
    Spallanzani, Andrea
    Gelsomino, Fabio
    Benatti, Stefania
    Luppi, Gabriele
    Melisi, Davide
    Dominici, Massimo
    Brandi, Giovanni
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [26] Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes
    Lowery, Maeve A.
    Goff, Laura W.
    Keenan, Bridget P.
    Jordan, Emmet
    Wang, Rui
    Bocobo, Andrea G.
    Chou, Joanne F.
    O'Reilly, Eileen M.
    Harding, Ames J.
    Kemeny, Nancy
    Capanu, Marianela
    Griffin, Ann C.
    McGuire, Joseph
    Venook, Alan P.
    Abou-Alfa, Ghassan K.
    Kelley, Robin K.
    CANCER, 2019, 125 (24) : 4426 - 4434
  • [27] Benefit of second-line chemotherapy for advanced biliary tract cancer.
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Bezan, Angelika
    Rossmann, Christopher
    Szkandera, Joanna
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Gemcitabine and platinum-based chemotherapy in first line treatment of hepatocholangiocarcinoma: An AGEO multicenter retrospective study
    Salimon, M.
    Prieux-Klotz, C.
    Tougeron, D.
    Lecomte, T.
    Caulet, M.
    Budnik, T. Matysiak
    Hautefeuille, V.
    Tiako-Meyo, M.
    Zaanan, A.
    Touchefeu, Y.
    ANNALS OF ONCOLOGY, 2017, 28
  • [29] The impact of second-line treatment after fist-line cisplatin plus gemcitabine in advanced biliary tract cancers: A mono-institutional retrospective study
    Gurreri, E.
    Chiaravalli, M.
    Bensi, M.
    Bagala, C.
    Di Stefano, B.
    Beccia, V.
    Spring, A.
    Monaca, F.
    Barone, D.
    Maratta, M.
    Tortora, G.
    Salvatore, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S302 - S302
  • [30] Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer:: a multicenter phase II trial
    Boeck, S.
    Weigang-Koehler, K.
    Fuchs, M.
    Kettner, E.
    Quietzsch, D.
    Trojan, J.
    Stoetzer, O.
    Zeuzem, S.
    Lordick, F.
    Koehne, C. -H.
    Kroening, H.
    Steinmetz, T.
    Depenbrock, H.
    Heinemann, V.
    ANNALS OF ONCOLOGY, 2007, 18 (04) : 745 - 751
12345